Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Who Can Receive Weight Loss Medications
Chinas weight-loss drug makers take on global giants as Novo Nordisk patent expires Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market Novo Nordisks blockbuster semaglutide, which generated about US$35 billion in global revenue last year, lost patent protection in China on March 20, clearing the way for rivals
PetrilloSPiermariniEPastoreAVascoGSchirinziTCarrozzoRet al
doi: 10.1016/j.molmet.2019.09.010 11 LeeY-SJunH-S
Q4 2025 Earnings Report
US$ 22.34
US$ 29.88
US$ 24.46
US$ 24.41
US$ 23.73
US$ 29.95
US$ 25.46
